Analyst Price Target is $26.50
▲ +23.26% Upside Potential
This price target is based on 4 analysts offering 12 month price targets for Alpha Teknova in the last 3 months. The average price target is $26.50, with a high forecast of $27.00 and a low forecast of $26.00. The average price target represents a 23.26% upside from the last price of $21.50.
Current Consensus is
The current consensus among 4 polled investment analysts is to buy stock in Alpha Teknova.
Alpha Teknova, Inc. provides reagents for bioprocessing, bioproduction, and molecular diagnostics. The company's reagents enable the discovery, research, development, and production of biopharmaceutical products, such as drug therapies, novel vaccines, and molecular diagnostics. It offers liquid culture, dry culture, agar, and animal-free media, as well as pre-poured plates, biological buffers, solutions, chemicals, and various treated and certified waters. The company was founded in 1996 and is based in Hollister, California.